Search Results - "Camps Herrero, Carlos"

Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer by Núñez Abad, Martín, Calabuig-Fariñas, Silvia, Lobo de Mena, Miriam, Torres-Martínez, Susana, García González, Clara, García García, José Ángel, Iranzo González-Cruz, Vega, Camps Herrero, Carlos

“…Breast cancer constitutes the most common malignant neoplasm in women around the world. Approximately 12% of patients are diagnosed with metastatic stage, and…”
Get full text

Update on systemic treatment in early triple negative breast cancer by Núñez Abad, Martín, Calabuig-Fariñas, Silvia, Lobo de Mena, Miriam, José Godes Sanz de Bremond, María, García González, Clara, Torres Martínez, Susana, García-García, José Ángel, Iranzo González-Cruz, Vega, Camps Herrero, Carlos

“…Triple negative breast cancer (TNBC) is a heterogeneous disease representing about 15% of all breast cancers. TNBC are usually high-grade histological tumors,…”
Get full text

Working towards a consensus on the oncological approach of breakthrough pain: a Delphi survey of Spanish experts by Camps Herrero, Carlos, Antón Torres, Antonio, Cruz-Hernández, Juan Jesús, Carrato, Alfredo, Constenla, Manuel, Díaz-Rubio, Eduardo, Feyjoo Saus, Margarita, Garcia-Foncillas, Jesus, Gascón, Pere, Guillem, Vicente

“…There is a lack of standards for the diagnosis, assessment and management of breakthrough cancer pain (BTcP). La Fundación ECO (the Foundation for Excellence…”
Get full text

Relation of Malnutrition and Nosocomical Infections in Cancer Patients in Hospital: An Observational Study by Muresan, Bianca Tabita, Núñez‐Abad, Martín, Artero, Ana, Rios Rios, Jaime, Cunquero-Tomás, Alberto Jacobo, Iranzo, Vega, Garrido, Javier, Jiménez-Portilla, Ana, Camps Herrero, Carlos, Sánchez Juan, Carlos J.

“…Aim. To investigate the relation between malnutrition and nosocomial infections (NI) in hospitalized cancer patients. Methods. This observational,…”
Get full text

Long term control stereotactic body radiotherapy (SBRT) for oligometastatic colorectal cancer: a single center study by Gil-Raga, Mireia, Meri-Abad, Marina, Safont Aguilera, Maria Jose, Hernández Machancoses, Ana, Lobo, Miriam, Calabuig-Fariñas, Silvia, López Torrecilla, Jose, Herreros Pomares, Alejandro, Camps Herrero, Carlos

“…To evaluate survival after stereotactic body radiotherapy (SBRT) as radical treatment for metastases of colorectal cancer (CRC) and to identify prognostic…”
Get full text

Role of RAS mutation status as a prognostic factor for patients with advanced colorectal cancer treated with first-line chemotherapy based on fluoropyrimidines and oxaliplatin, with or without bevavizumab: A retrospective analysis by Garde Noguera, Javier, Jantus-Lewintre, Eloisa, Gil-Raga, Mireia, Evgenyeva, Elena, Maciá Escalante, Sonia, Llombart-Cussac, Antonio, Camps Herrero, Carlos

“…The role of Kirsten rat sarcoma viral oncogene homolog (KRAS) and neuroblastoma RAS viral oncogene homolog (NRAS) mutations as negative predictors for…”
Get full text

Professional survey on knowledge and clinical patterns of pain management in Spanish medical oncology by Escobar Álvarez, Yolanda, Rodríguez Sánchez, César A., Caballero Martínez, Fernando, Recuero Cuervo, Virginia, Camps Herrero, Carlos

“…Cancer pain is still not treated adequately. The barriers impeding its appropriate treatment include lack of knowledge, erroneous beliefs and inappropriate…”
Get full text

Identification of quality care standards and development of indicators in oncology by Camps-Herrero, Carlos

“…Abstract only 239 Background: Continuous assessment of clinical practice is a fundamental strategy for improving quality care. The generation of indicators in…”
Get full text

Oncologists’ perceptions of cancer pain management in Spain: The real and the ideal by Carulla Torrent, Joan, Jara Sánchez, Carlos, Sanz Ortiz, Jaime, Batista López, Norberto, Camps Herrero, Carlos, Cassinello Espinosa, Javier, Lizón Giner, José, Montalar Salcedo, Joaquı´n, Fitch Warner, Kathryn, Gobbo Montoya, Milena, Dı´az-Rubio García, Eduardo

“…Abstract Aim Studies in some countries suggest that cancer pain is often not adequately controlled, but little is known about the situation in Spain. The…”
Get full text

Clinical and technical insights of tumour mutational burden in non-small cell lung cancer by Meri-Abad, Marina, Moreno-Manuel, Andrea, García, Sandra Gallach, Calabuig-Fariñas, Silvia, Pérez, Rafael Sirera, Herrero, Carlos Camps, Jantus-Lewintre, Eloisa

“…Despite the durable responses provided by the introduction of checkpoint inhibitors in advanced Non-Small Cell Lung Cancer (NSCLC) without actionable targets…”
Get full text

Capillary and cutaneous hypopigmentation secondary to pazopanib by Meri-Abad, Marina, Blasco Cordellat, Ana, Camps Herrero, Carlos

Get full text

Nutritional assessment and intervention in hospitalized cancer patients at risk of or with malnutrition: evaluation of the effect on anthropometric and body composition parameters by Muresan, Bianca Tabita, Jiménez-Portilla, Ana, Artero, Ana, Ruiz Berjaga, Yesica, Llamas Montero, María Del Mar, Lobo de Mena, Miriam, Camps Herrero, Carlos, Sánchez Juan, Carlos

“…Introduction: malnutrition is a common problem in cancer patients that worsens during hospitalization and is associated with increased morbidity and mortality,…”
Get full text

A 68-year-old woman with dancing eyes syndrome by Merí Abad, Marina, Aparisi Aparisi, Francisco de Asís, Blasco Cordellat, Ana, Camps Herrero, Carlos

Get full text

SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan by De las Peñas, Ramón, Ponce, Santiago, Henao, Fernando, Camps Herrero, Carlos, Carcereny, Enric, Escobar Álvarez, Yolanda, Rodríguez, César A., Virizuela, Juan Antonio, López López, Rafael

“…Hyponatremia (Na ˂135 mmol/l) is the most frequent electrolyte disorder in clinical practice, and the syndrome of inappropriate antidiuretic hormone secretion…”
Get full text

Epidemiology and characteristics of febrile neutropenia in oncology patients from Spanish tertiary care hospitals: PINNACLE study by DE CASTRO CARPEÑO, JAVIER, GASCÓN-VILAPLANA, PERE, TEJERINA, ANA MARIA CASAS-FERNÁNDEZ-DE, ANTÓN-TORRES, ANTONIO, LÓPEZ-LÓPEZ, RAFAEL, BARNADAS-MOLINS, AGUSTÍ, CRUZ-HERNÁNDEZ, JUAN JESÚS, MASSUTI-SUREDA, BARTOMEU, CAMPS-HERRERO, CARLOS, ARANDA-AGUILAR, ENRIQUE, LASERNA, FRANCISCO JOSÉ REBOLLO

“…Febrile neutropenia (FN) is one of the most common adverse events associated with myelosuppressive chemotherapy for cancer treatment. The objective of this…”
Get full text

Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients by Alberola Candel, Vicente, Carrato Mena, Alfredo, Díaz-Rubio García, Eduardo, Gascón Vilaplana, Pere, González Barón, Manuel, Martín Jiménez, Miguel, Alba Conejo, Emilio, Cassinello Espinosa, Javier, Colomer, Ramon, Cruz Hernández, Juan Jesús, Barnadas i Molins, Agustí, Camps Herrero, Carlos, Casas Fernández de Tejerina, Ana Ma, Carulla Torrent, Joan, Constenla Figueiras, Manuel, Gavilá Gregori, Joaquin, Isla Casado, Ma. Dolores, Massuti Sureda, Bartomeu, Provencio Pulla, Mariano, Rodríguez Sánchez, César Augusto, Sanz Ortiz, Jaime

“…Treatment of anaemia is a very important aspect in the management of cancer patients. In order to carry out a consensus process about the use of erythropoietic…”
Get full text

Analysis of tumour-derived DNA in serum in advanced non-microcytic lung cancer: might it be a prognostic factor? by Camps Herrero, Carlos, Bayo Zaera, Pilar, Sirera Pérez, Rafael, Sancho Salvador, Eva, Blasco Cordellat, Ana, Safont Aguilera, María José

“…Presence of circulating DNA in the serum of patients with cancer makes detection of tumour-specific genetic alterations feasible. To study serum DNA…”
Get full text

Second-line treatment with gemcitabine and vinorelbine in non-small-cell lung cancer (NSCLC) cisplatin failures: a pilot study by Herrero, Carlos Camps, Noguerón Martı́nez, Esther, Jaime, Alfonso Berrocal

“…Purpose: This pilot study was designed to evaluate the efficacy and toxicity of the gemcitabine/vinorelbine combination in non-small-cell lung cancer (NSCLC)…”
Get full text

Euthanasia in patients with cancer and the continuous-care providers by Camps Herrero, Carlos, Gavilá Gregori, Joaquín, Garde Noguera, Javier, Caballero Díaz, Cristina, Iranzo González-Cruz, Vega, Juárez Marroquí, Asunción, Safont Aguilera, Maria José, Blasco Cordellat, Ana, Berrocal Jaime, Alfonso, Sanz de Bremond, Maria Godes

“…During the clinical evolution of patients with cancer there are many occasions, or phases of the disease, when there are no specific treatments and, as such,…”
Get full text

Estudio de utilización de pemetrexed en el cáncer de pulmón no microcítico by Blasco Segura, Pilar, Villanueva Herraiz, Sandra, Ortega García, Mª Pilar, Camps Herrero, Carlos

“…Estudiar la efectividad y la seguridad del pemetrexed en el cáncer de pulmón no microcítico. Estudio retrospectivo (marzo 2006–mayo 2008) de utilización de…”
Get full text